NUS Links:
This study reports a novel inhibitor oxide (MPO) which promotes inhibition of growth in pancreatic and hepatocellular cancer cell lines by inducing cell cycle arrest. Hence authors in this study led by Prof Shazib Pervaiz provide proof-of-concept for therapeutic potential of this novel inhibitor against cancers.
Link to website: https://bit.ly/3HQnIsb
Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …
Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …
Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment …